Target intelligence / Profile preview

Gastrointestinal tract nutrient absorption (None)

Target
None
Molecular classification
Transporter, Channel, Receptor, Enzyme
01

Overview

Gastrointestinal tract nutrient absorption" refers broadly to the physiological processes by which digested food molecules—including sugars, amino acids, fatty acids, vitamins, minerals and water—are transported from the lumen of the gastrointestinal tract across intestinal epithelial cells into blood or lymphatic circulation for use throughout the body. This occurs primarily in the small intestine through specialized structures called villi and microvilli that maximize surface area for efficient transfer. Absorptive mechanisms involve several classes of membrane proteins including sodium-glucose co-transporter type 1 (SGLT1) for glucose uptake; peptide transporter type 1 (PEPT1) for di/tripeptides; facilitative glucose transporters (GLUTs) such as GLUT5 and GLUT2; amino acid cotransporters; fatty acid binding proteins; ion channels; and others. Some transporters also serve sensory functions by triggering hormone release from enteroendocrine cells in response to luminal nutrients—a key part in regulating appetite/metabolism via hormones like GLP‑1. Disorders affecting these processes can result in clinical syndromes ranging from genetic malabsorptions to acquired conditions like celiac disease or consequences seen in obesity/metabolic syndrome due to altered transporter expression/functionality[2][3][5]. Drugs may modulate these pathways indirectly but there is no single “gastrointestinal tract nutrient absorption” druggable entity.

Other names
Intestinal nutrient absorptionGI nutrient uptakeSmall intestine absorption
02

Mechanism of action

Not applicable at the level of this broad term.

03

Biological functions

Nutrient uptake/absorptionEnergy homeostasis regulationHormone secretion via enteroendocrine signalingMaintenance of fluid/electrolyte balance
04

Disease associations

Malabsorption syndromes (e.g., celiac disease)Metabolic diseases (e.g., obesity, diabetes)Genetic disorders affecting transporters (e.g., glucose-galactose malabsorption due to SGLT1 mutations)
05

Safety considerations

Risk of malnutrition/malabsorption if over-inhibitedElectrolyte imbalances
06

Biomarkers

Stool fat content for fat malabsorptionBlood levels of vitamins/minerals/amino acids/glucose after oral challenge tests

Beyond the preview

Go deeper on Gastrointestinal tract nutrient absorption (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal tract nutrient absorption (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call